BIOTECHNOLOGY VALUE FUND L P - 30 Sep 2025 SCHEDULE 13G/A Report for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share
Symbol
PVLA
Shares outstanding
11,823,764 shares
Disclosed Ownership
1,181,194 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:19:50 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 5.4% 634,307 0 634,307 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 5.4% 634,307 0 634,307 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4% 474,740 0 474,740 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4% 474,740 0 474,740 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.5% 54,840 0 54,840 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.5% 54,840 0 54,840 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.4% 1,109,047 0 1,109,047 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 10% 1,181,194 0 1,181,194 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 10% 1,181,194 0 1,181,194 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 10% 1,181,194 0 1,181,194 /s/ Mark N. Lampert Mark N. Lampert